Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations.
paper
Cited
Public
Unavailable
- Authors
- Tan, Ene-Choo; Tan, Chay-Hoon; Karupathivan, Umavathy; Yap, Eric P H
- Year
- 2003
- Journal
- Neuroreport
- PMID
- 12657887
- DOI
- 10.1097/00001756-200303240-00008
The distribution of three polymorphisms of the mu opioid receptor gene (OPRM1) was investigated in four different Asian populations, and in heroin-dependent subjects deriving from three of these populations. For the A118G polymorphism, we found significant differences in allele and genotype frequencies between different ethnic groups and highly significant association with heroin dependence in Indians for both genotype distribution (p = 0.024) and allele frequency (p = 0.009). For the C17 T polymorphism, the minor allele was documented in Chinese and Malays for the first time. Molecular haplotyping revealed complete linkage dis-equilibrium between the A118G and C17 T polymorphisms. Linkage disequilibrium between the A118G and C1031G polymorphisms was found to be almost complete in all four ethnic groups.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Allele frequency and genotype distribution of the opioid receptor ΞΌ-1 (OPRM1) A118G polymorphism in the Western Saudi population. | Bagher AM et al. | β | 2023 | β |
| Association of Mu opioid receptor (A118G) and BDNF (G196A) polymorphisms with rehabilitation-induced cortical inhibition and analgesic response in chronic osteoarthritis pain. | GonΓ§alves FT et al. | β | 2023 | β |
| Nicotine and opioid co-dependence: Findings from bench research to clinical trials. | Custodio L et al. | β | 2022 | β |
| Pharmacogenetics of Addiction Therapy. | Graham DP et al. | β | 2022 | β |
| Differential behavioral functioning in the offspring of rats with high vs. low self-administration of the opioid agonist remifentanil. | Rezvani AH et al. | β | 2021 | β |
| Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism. | Cornett EM et al. | β | 2020 | β |
| Relapse-like behavior in a mouse model of the OPRM1 (mu-opioid receptor) A118G polymorphism: Examination with intravenous oxycodone self-administration. | Zhang Y et al. | β | 2020 | β |
| Social withdrawal: An initially adaptive behavior that becomes maladaptive when expressed excessively. | Ike KGO et al. | β | 2020 | β |
| The pharmacogenetics of opioid treatment for pain management. | Singh A et al. | β | 2020 | β |
| The Streetlight Effect: Reappraising the Study of Addiction in Light of the Findings of Genome-wide Association Studies. | Hall FS et al. | β | 2020 | β |
| A review of opioid addiction genetics. | Crist RC et al. | β | 2019 | β |
| Binge-Like Eating Is Not Influenced by the Murine Model of <i>OPRM1</i> A118G Polymorphism. | Sachdeo BLY et al. | β | 2019 | β |
| Dopamine and opioid systems adaptation in alcoholism revisited: Convergent evidence from positron emission tomography and postmortem studies. | Hansson AC et al. | β | 2019 | β |
| Increased risk of intracranial hemorrhage in preterm infants with OPRM1 gene A118G polymorphism. | Cheng XR et al. | β | 2019 | β |
| <i>OPRM1</i> A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches. | Taqi MM et al. | β | 2019 | β |
| Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders. | Burns JA et al. | β | 2019 | β |
| Pharmacogenetics of alcohol addiction: current perspectives. | Zastrozhin MS et al. | β | 2019 | β |
| Racial differences in experimental pain sensitivity and conditioned pain modulation: a study of Chinese and Indians. | Ng TS | β | 2019 | β |
| Synaptic Regulation by OPRM1 Variants in Reward Neurocircuitry. | Popova D et al. | β | 2019 | β |
| The association between the OPRM1 A118G polymorphism and addiction in a Turkish population. | TΓΌrkan H et al. | β | 2019 | β |
| The influence of the OPRM1 (A118G) polymorphism on behavioral and neural correlates of aggression in healthy males. | Weidler C et al. | β | 2019 | β |
| Allelic frequencies of 60 pharmacogene variants assessed within a Burmese population residing in northeast Indiana, USA. | Hoefer CC et al. | β | 2018 | β |
| Implication of OPRM1 A118G Polymorphism in Opioids Addicts in Pakistan: In vitro and In silico Analysis. | Ahmed M et al. | β | 2018 | β |
| Increased ethanol drinking in "humanized" mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms. | Henderson-Redmond AN et al. | β | 2018 | β |
| Prevalence Rates of Personality Disorder and Its Association With Methamphetamine Dependence in Compulsory Treatment Facilities in China. | Zhang C et al. | β | 2018 | β |
| The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review. | Oueslati B et al. | β | 2018 | β |
| Association of opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with nicotine dependence. | Kong X et al. | β | 2017 | β |
| Lack of associations of the opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with alcohol dependence: review and meta-analysis of retrospective controlled studies. | Kong X et al. | β | 2017 | β |
| A gene-by-sex interaction for nicotine reward: evidence from humanized mice and epidemiology. | Bernardi RE et al. | β | 2016 | β |
| Alcohol addiction and the mu-opioid receptor. | Berrettini W | β | 2016 | β |
| Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts. | Schwantes-An TH et al. | β | 2016 | β |
| Morphine-induced antinociception and reward in "humanized" mice expressing the mu opioid receptor A118G polymorphism. | Henderson-Redmond AN et al. | β | 2016 | β |
| Opioid neuroscience for addiction medicine: From animal models to FDA approval for alcohol addiction. | Berrettini W | β | 2016 | β |
| A6V polymorphism of the human ΞΌ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro. | Knapman A et al. | β | 2015 | β |
| A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice. | Bilbao A et al. | β | 2015 | β |
| Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human ΞΌ-opioid receptor (OPRM1). | Knapman A et al. | β | 2015 | β |
| Mouse model of OPRM1 (A118G) polymorphism increases sociability and dominance and confers resilience to social defeat. | Briand LA et al. | β | 2015 | β |
| Opioid receptor A118G polymorphism does not affect the consumption of sufentanil and ropivacaine by patient-controlled epidural analgesia after cesarean section. | Xu GH et al. | β | 2015 | β |
| The Opposing Roles of IVS2+691 CC Genotype and AC/AG Diplotype of 118A>G and IVS2+691G>C of OPRM1 Polymorphisms in Cold Pain Tolerance Among Opioid-Dependent Malay Males on Methadone Therapy. | Zahari Z et al. | β | 2015 | β |
| The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review. | Bauer IE et al. | β | 2015 | β |
| Introduction to deep sequencing and its application to drug addiction research with a focus on rare variants. | Wang S et al. | β | 2014 | β |
| Mu opioid receptor gene: new point mutations in opioid addicts. | Dinarvand A et al. | β | 2014 | β |
| Pharmacogenetics of addiction therapy. | Nielsen DA et al. | β | 2014 | β |
| Pharmacogenetics of OPRM1. | Crist RC et al. | β | 2014 | β |
| Case-control association analysis of polymorphisms in the Ξ΄-opioid receptor, OPRD1, with cocaine and opioid addicted populations. | Crist RC et al. | β | 2013 | β |
| Case-control association study of WLS variants in opioid and cocaine addicted populations. | Crist RC et al. | β | 2013 | β |
| Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside? | Mura E et al. | β | 2013 | β |
| Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain. | Gong XD et al. | β | 2013 | β |
| Genetic contributions to labor pain and progress. | Landau R | β | 2013 | β |
| Implications of genome wide association studies for addiction: are our a priori assumptions all wrong? | Hall FS et al. | β | 2013 | β |
| Influence of mu-opioid receptor variant on morphine use and self-rated pain following abdominal hysterectomy. | Sia AT et al. | β | 2013 | β |
| Low frequency genetic variants in the ΞΌ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine. | Clarke TK et al. | β | 2013 | β |
| Mu opioids and their receptors: evolution of a concept. | Pasternak GW et al. | β | 2013 | β |
| Opioid pharmacogenetics of alcohol addiction. | Berrettini W | β | 2013 | β |
| Opioid receptor polymorphism A118G associated with clinical severity in a drug overdose population. | Manini AF et al. | β | 2013 | β |
| Opioid therapy pharmacogenomics for noncancer pain: efficacy, adverse events, and costs. | Xu Y et al. | β | 2013 | β |
| OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study. | Chen YT et al. | β | 2013 | β |
| OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis. | Haerian BS et al. | β | 2013 | β |
| The associations between OPRM 1 and COMT genotypes and postoperative pain, opioid use, and opioid-induced sedation. | Henker RA et al. | β | 2013 | β |
| The ΞΌ-opioid receptor and treatment response to naltrexone. | Thorsell A | β | 2013 | β |
| A118G mu opioid receptor polymorphism among drug addicts in Malaysia. | Nagaya D et al. | β | 2012 | β |
| A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women. | Crystal HA et al. | β | 2012 | β |
| Association study of the Ξ²-arrestin 2 gene (ARRB2) with opioid and cocaine dependence in a European-American population. | Ambrose-Lanci LM et al. | β | 2012 | β |
| Close association between A118G single nucleotide polymorphism and opioid, alcohol, and nicotine dependence. | Kapoor S | β | 2012 | β |
| Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value. | Mathews R et al. | β | 2012 | β |
| Human mu-opioid receptor gene A118G polymorphism predicts the efficacy of tramadol/acetaminophen combination tablets (ultracet) in oxaliplatin-induced painful neuropathy. | Liu YC et al. | β | 2012 | β |
| Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study. | Ray LA et al. | β | 2012 | β |
| Pharmacogenomic considerations in opioid analgesia. | Vuilleumier PH et al. | β | 2012 | β |
| The genetics of substance dependence. | Wang JC et al. | β | 2012 | β |
| The genetics of the opioid system and specific drug addictions. | Levran O et al. | β | 2012 | β |
| The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. | Ray LA et al. | β | 2012 | β |
| Genetic variability of pain perception and treatment--clinical pharmacological implications. | LΓΆtsch J | β | 2011 | β |
| Molecular mechanisms of opioid receptor-dependent signaling and behavior. | Al-Hasani R et al. | β | 2011 | β |
| No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample. | Nikolov MA et al. | β | 2011 | β |
| Pharmacogenomics of the human Β΅-opioid receptor. | Kasai S et al. | β | 2011 | β |
| Ξ²2-adrenergic receptor genotype and other variables that contribute to labor pain and progress. | Reitman E et al. | β | 2011 | β |
| Association of human micro-opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients. | Zhang W et al. | β | 2010 | β |
| Association of the functional A118G polymorphism of OPRM1 in diabetic patients with foot ulcer pain. | Cheng KI et al. | β | 2010 | β |
| Genetics of drug dependence. | Gelernter J et al. | β | 2010 | β |
| Observational study of the effect of mu-opioid receptor genetic polymorphism on intrathecal opioid labor analgesia and post-cesarean delivery analgesia. | Wong CA et al. | β | 2010 | β |
| OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. | Mague SD et al. | β | 2010 | β |
| Pharmacogenetic influences in obstetric anaesthesia. | Landau R | β | 2010 | β |
| Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatment. | Mroziewicz M et al. | β | 2010 | β |
| Pharmacogenetics in obstetric anesthesia. | Landau R et al. | β | 2010 | β |
| Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment. | Khokhar JY et al. | β | 2010 | β |
| Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction. | Deb I et al. | β | 2010 | β |
| Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism. | Ray LA et al. | β | 2010 | β |
| Dopamine for "wanting" and opioids for "liking": a comparison of obese adults with and without binge eating. | Davis CA et al. | β | 2009 | β |
| Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain. | Tan EC et al. | β | 2009 | β |
| Genetic modulation of the pharmacological treatment of pain. | LΓΆtsch J et al. | β | 2009 | β |
| Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis. | Coller JK et al. | β | 2009 | β |
| Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. | Mague SD et al. | β | 2009 | β |
| Novel linkage disequilibrium of single nucleotide polymorphisms in the transcriptional regulatory region of micro-opioid receptor gene in Japanese population. | Ono T et al. | β | 2009 | β |
| A functional polymorphism of the micro-opioid receptor gene is associated with completed suicides. | Hishimoto A et al. | β | 2008 | β |
| Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype. | Hayashida M et al. | β | 2008 | β |
| Candidate gene polymorphisms predicting individual sensitivity to opioids. | Kasai S et al. | β | 2008 | β |
| [Genetic polymorphisms and opioid therapies]. | Landau R | β | 2008 | β |
| Pharmacogenetics and obstetric anesthesia. | Landau R | β | 2008 | β |
| The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. | Zhang H et al. | β | 2008 | β |
| A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin. | Kapur S et al. | β | 2007 | β |
| Basic genetic statistics are necessary in studies of functional associations in anesthesiology. | LΓΆtsch J | β | 2007 | β |
| Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis. | Glatt SJ et al. | β | 2007 | β |
| Pharmacogenetics and obstetric anesthesia. | Landau R | β | 2007 | β |
| The opioid system in alcohol and drug dependence: family-based association study. | Xuei X et al. | β | 2007 | β |
| A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain. | Janicki PK et al. | β | 2006 | β |
| Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. | Zhang H et al. | β | 2006 | β |
| Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. | Arias A et al. | β | 2006 | β |
| Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. | Chou WY et al. | β | 2006 | β |
| Genomewide linkage scan for opioid dependence and related traits. | Gelernter J et al. | β | 2006 | β |
| Perspectives on current directions in the neurobiology of addiction disorders relevant to genetic risk factors. | Hurd YL | β | 2006 | β |
| Pharmacogenetics of opioid receptors and addiction. | Mayer P et al. | β | 2006 | β |
| Singapore Human Mutation/Polymorphism Database: a country-specific database for mutations and polymorphisms in inherited disorders and candidate gene association studies. | Tan EC et al. | β | 2006 | β |
| Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone. | Oslin DW et al. | β | 2006 | β |
| The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress. | Chong RY et al. | β | 2006 | β |
| Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. | Zhang Y et al. | β | 2005 | β |
| Are mu-opioid receptor polymorphisms important for clinical opioid therapy? | LΓΆtsch J et al. | β | 2005 | β |
| Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. | Bart G et al. | β | 2005 | β |
| Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. | Kreek MJ et al. | β | 2005 | β |
| Pharmacogenetics: implications for obstetric anesthesia. | Landau R | β | 2005 | β |
| The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. | Fillingim RB et al. | β | 2005 | β |
| A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. | Ray LA et al. | β | 2004 | β |
| Association of functional opioid receptor genotypes with alcohol dependence in Koreans. | Kim SG et al. | β | 2004 | β |
| Comprehensive mu-opioid-receptor genotyping by pyrosequencing. | Skarke C et al. | β | 2004 | β |
| Evolving perspectives on neurobiological research on the addictions: celebration of the 30th anniversary of NIDA. | Kreek MJ et al. | β | 2004 | β |
| Genes associated with addiction: alcoholism, opiate, and cocaine addiction. | Kreek MJ et al. | β | 2004 | β |
| Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives. | LΓΆtsch J et al. | β | 2004 | β |
| Genetics and drug use as a complex phenotype. | Lessov CN et al. | β | 2004 | β |